Fosfomycin Synergy In Vitro with Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with Infected Urinary Stents

Fosfomycin is a potential option for vancomycin-resistant enterococcus (VRE) infections despite limited in vitro and clinical data. In this study, 32 VRE isolates from renal transplant patients with urinary stent infections were susceptible to fosfomycin, daptomycin, and linezolid and resistant to a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Descourouez, Jillian L., Jorgenson, Margaret R., Wergin, Justine E., Rose, Warren E.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2013
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3591908/
https://ncbi.nlm.nih.gov/pubmed/23263002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02099-12
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars